Background Helicobacter pylori infection is still frequent in the community and all infected
subjects should be offered an eradication therapy. Nowadays physicians have to face the …

Helicobacter pylori infection still represents a major health issue, especially in developing
countries, with an estimate of 4 billion of infected subjects in 2015. The increase of antibiotic …

The management of Helicobacter pylori infection is still surrounded by controversy and
uncertainties. Indications and correct application of current regimens for Helicobacter pylori …

The publication of the National Institutes of Health Consensus Development Conference
guidelines on management of Helicobacter pylori infection in 1994 set a precedence. At …

Eradication rates of first-line triple therapy for Helicobacter pylori infection have fallen in the
recent years. The main reasons for treatment failure are poor compliance due to complicated …

Helicobacter pylori is one of the most common human pathogens and it has been estimated
that about 50% of the world's population is currently infected. The present consensus is that …

As an update to previously published recommendations for the management of Helicobacter
pylori infection, an evidence‐based appraisal of six topics was undertaken in a consensus …

Helicobacter pylori infection is a serious, chronic, transmissible, infectious disease in which
clinical disease typically is preceded by a long asymptomatic period. In many ways infection …

An effective Helicobacter pylori therapy reliably provides high cure rates in infections with
susceptible strains. It is possible to predict the efficacy of any regimen if one knows the …

The eradication of Helicobacter pylori not only heals peptic ulcers but also prevents their
recurrence and reduces the risk of development of gastric cancer and other H. pylori …